| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |